time, leading to crippling complications, severe disabilities and/or relatively slow deaths. For some of these chronic conditions, therapeutic and preventive solutions are available but are almost not utilized, which further adds to the irony of them being labelled as 'non-neglected'. With respect to some of these neglected (infectious and chronic) conditions, we discuss some aspects of the contributions made by Prof. Michel Dumas and Prof. Pierre-Marie Preux to the advancement of epidemiology and neurology, the development of scientific acumen and clinical capacity, and in turn the improvement of the state of public health in various tropical regions ( table 1 ) .
Dementia
Dementia is an important public health problem in tropical countries. They initiated and developed longterm research and action programs for dementia in several Central African countries, despite periodic bouts of civil unrest there [2] [3] [4] . They also identified a tool for determining the accurate age of dementia subjects -an extremely important issue in dementia research [5] -as well as certain psychosocial factors important in the survival of demented subjects [2] .
Human T-Lymphotropic Virus Type 1
Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus implicated in a number of disorders, and they were one of the first groups to have conducted several surveys in West Africa to determine the seroprevalence and incidence of HTLV-1, and to have demonstrated a familial transmission and clustering of this viral disease in this subregion [6, 7] . They had also demonstrated a correlation of HTLV-1 with spastic paraparesis, as well as with lifestyle, environmental and geographic factors, and with concomitant infections such as filariasis. For the first time, they had validated the lot quality assurance sampling method for field application to detect small clusters of infection.
Central Nervous System Infections
Their surveys and projects have helped to fill 'knowledge gaps' about several central nervous system infections in tropical Africa. Particularly, these central nervous system infections included onchocerciasis and cysticercosis [8] . Interest by other research agencies in sleeping sickness (SS) has long declined in favor of other popular infections. However, they conducted several research and action programs for SS in tropical Africa that particularly helped to determine: appropriate trypanocidal (mono and combination) therapies for second-stage SS; the regulatory role of several antibodies [9] and cytokines; and the development of validated models for carrying out immunopathological, neurohistological and therapeutic studies on SS [10] . The development of chronic experimental models for SS in animals with cerebral lesions and neurological disorders had been a matter of difficulty then [10] . 
Epilepsy
Their research action programs have recently demonstrated an epileptogenic role of malaria in Mali [11] and Gabon [12] . For this, in 2009 the Bruce S. Schoenberg International Award in Neuroepidemiology went to the principal investigator from Gabon (Prof. Edgard Ngoungou). This was the first time that someone from tropical Africa became an awardee. He is an ex-student of Prof. PierreMarie Preux, and interestingly received a 'letter of appreciation' from the President of Gabon as well (read: recognition of tropical experts through organized research).
Their estimates of the prevalence of epilepsy in Asia and sub-Saharan Africa are considered authoritative and are widely used. Their Limoges epilepsy screening questionnaire is also widely used in tropical countries and has helped to standardize data collection on epilepsy. They have recently demonstrated a greater benefit of using individual, rather than household, questionnaires for determining the burden of neurological disorders in low-income countries [13] .
Their recent activities on epilepsy in Asia have culminated in numerous first-time results, for instance: (a) validated epidemiological tools for rating self-esteem, fear, social support, discrimination, coping strategies, patientderived quality of life, etc. [14] ; (b) an estimate of the annual requirement of two antiepileptic drugs in an Asian country (i.e. Cambodia); and (c) the validation of reproductive causality in epilepsy and a precise estimate of the preventability of epilepsy [15] . Besides this they are among 142 the first researchers who have shown in Asia that not all epileptic populations are stigmatized, although stigma is nearly always accorded to epilepsy 'by default' [15] . In addition, some years ago they also demonstrated a two-way correlation of epilepsy with malnutrition in Africa [16] . Recently, experts of a parent body on epilepsy have repeatedly recommended that the activities regarding epilepsy in Asia (particularly in Cambodia) be a 'model for investigation of epilepsy in developing countries'. Several activities in epilepsy research are proceeding in a neighboring country, Laos, where the two researchers were the first and only to determine the true burden of epilepsy as well as several other, particularly treatment-related, aspects of epilepsy [17, 18] .
Although training of local staff is often recommended as a means of bridging manpower and, consequently, the treatment gap in epilepsy [19] , little thought has been given to which staff should be trained, since not just doctors but also neurologists, psychiatrists, nurses, pharmacists and midwives are insufficient in number and are also inequitably distributed. Very recently they have been instrumental in identifying a 'new' service provider (i.e. primary health center staff) for providing trained epilepsy care at a primary care level. For many reasons, this strategy is extremely suitable, especially for rural populations [19] . Based on this strategy, a provincial program for epilepsy has very recently been started in two Asian countries [19] ; this is a rare achievement, since there are not many countries where a formal provincial/national program for epilepsy has been, or is, running. Interestingly, in the case of Cambodia, it took merely 3 years to progress from conducting a first-ever prevalence survey to starting a formal provincial program for epilepsy. Also, for the first time, a new strategy named 'domestic health visiting' has been devised and is also being tested to reach epilepsy patient populations in a standard, organized, professional and regular manner in two Asian countries [19] .
Capacity Building
This is one of their most important contributions toward improvement of the health care system of recipient countries. Apart from extensive teaching activities at various home institutions, they have raised a whole new generation of researchers, neurologists and epidemiologists in the last three decades, most of whom are working in their home countries. As an example, where no neurologists existed 15 years ago, today 7 neurologists and 1 neurorehabilitation specialist are available in Cambodia [20] .
Besides this the two professors have also trained several provincial practitioners (primary health center staff and general practitioners) in several African and Asian countries; many of such training programs are currently going on as well [20] .
Miscellaneous
In another valuable contribution, they were instrumental in conducting a three-country survey of mutiple sclerosis (MS) that came out with extremely novel findings on the risk and prevention of MS [21] . In particular, outdoor leisure activities, in addition to sun exposure, were for the first time found to be associated with reduced risk of MS, with evidence of a dose-response relationship. This survey had received much appreciation from the experts working in the field of MS.
Low-income countries are rarely chosen as priority locations for conducting advocacy events and professional and academic exchanges. As an example, a parent organization for epilepsy has conducted only 4 congresses in a low-income location since 1909 and none at a lowincome location in the last 10 years. Due to the professors' efforts, low-income locations have been chosen 'with priority' to conduct such events, like the ones in Cambodia, Vietnam and recently in Paris, France, in which experts from 16 low-income countries (Asia, Africa and Latin America) were specifically invited and given travel bursaries to be able to participate. Another such event is currently being organized in Varetz, France, and experts from several low-income countries have been specifically given travel bursaries. Such events are important for the advocacy, direct participation of public and private stakeholders, and motivation as well as encouragement of local expertise.
The professors have also been extremely active regarding ALS, having created a first-ever register in Franceone of the only three such efforts in Europe [22] . Their institute is also France's sole ALS expert center. They have been among the few research groups to have actively utilized geoepidemiological tools in ALS research to identify aggregate zones of ALS in France. They have provided one of the few sources of knowledge about ALS from Africa and have since long established an active consortium of African neurologists and researchers working on ALS, called TROPALS (Study of ALS under the Tropics; www.tropals.unilim.fr/). Several nutritional factors and environmental toxins have been identified that serve as risk, prognostic and diagnostic factors for ALS. 143 Due to limitations of space, many of their contributions have not been discussed here in detail, for instance: (a) the facilitation of programs of professional and academic exchange [20] ; (b) the prioritization of silent diseases and 'silent countries' (e.g. ALS in Africa, MS in Cuba and Martinique, countries like Mali, Martinique, Burundi, Cambodia, etc.); (c) their contribution in the development of 'early neurology' in Africa (in the 1960s); (d) the development of time-tested public-private partnerships, which are often crucial for sustaining research action programs; and (e) treatment programs for epilepsy that continue to bring people out of the 'epilepsy shadow' in many African and Asian countries.
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